Circulating immune complexes in IgA nephropathy consist of IgA1 with galactose-deficient hinge region and antiglycan antibodies.
Circulating immune complexes (CICs) isolated from sera of patients with IgA nephropathy (IgAN) consist of undergalactosylated, mostly polymeric, and J chain-containing IgA1 and IgG antibodies specific for N-acetylgalactosamine (GalNAc) residues in O-linked glycans of the hinge region of IgA1 heavy chains. Antibodies with such specificity occur in sera of IgAN patients, and in smaller quantities in patients with non-IgA proliferative glomerulonephritis and in healthy controls; they are present mainly in the IgG (predominantly IgG2 subclass), and less frequently in the IgA1 isotype. Their specificity for GalNAc was determined by reactivity with IgA1 myeloma proteins with enzymatically removed N-acetylneuraminic acid (NeuNAc) and galactose (Gal); removal of the O-linked glycans of IgA1 resulted in significantly decreased reactivity. Furthermore, IgA2 proteins that lack the hinge region with O-linked glycans but are otherwise structurally similar to IgA1 did not react with IgG or IgA1 antibodies. The re-formation of isolated and acid-dissociated CICs was inhibited more effectively by IgA1 lacking NeuNAc and Gal than by intact IgA1. Immobilized GalNAc and asialo-ovine submaxillary mucin (rich in O-linked glycans) were also effective inhibitors. Our results suggest that the deficiency of Gal in the hinge region of IgA1 molecules results in the generation of antigenic determinants containing GalNAc residues that are recognized by naturally occurring IgG and IgA1 antibodies.
Department of Medicine, Division of Clinical Immunology and Rheumatology, The University of Alabama-Birmingham, Birmingham, Alabama 35294-2041, USA. mtomana@uab.campuscwix.net
M
M
Tomana
J
J
Novak
B A
BA
Julian
K
K
Matousovic
K
K
Konecny
J
J
Mestecky
D000116:Acetylgalactosamine / Q000276:immunology*; D000328:Adult; D000918:Antibody Specificity; D000936:Antigen-Antibody Complex / Q000737:chemistry*; D001323:Autoantibodies / Q000276:immunology* / Q000302:isolation & purification; D001324:Autoantigens / Q000737:chemistry / Q000276:immunology*; D002236:Carbohydrate Conformation; D002240:Carbohydrate Sequence; D000939:Epitopes / Q000276:immunology; D005260:Female; D005690:Galactose / Q000032:analysis*; D005920:Glomerular Mesangium / Q000276:immunology; D005922:Glomerulonephritis, IGA / Q000276:immunology*; D006031:Glycosylation; D006801:Humans; D007070:Immunoglobulin A / Q000276:immunology* / Q000302:isolation & purification; D007074:Immunoglobulin G / Q000276:immunology; D008297:Male; D008875:Middle Aged; D008969:Molecular Sequence Data; D009194:Myeloma Proteins / Q000276:immunology; D009439:Neuraminidase / Q000494:pharmacology; D011134:Polysaccharides / Q000737:chemistry / Q000276:immunology*; D011499:Protein Processing, Post-Translational
D000936:Antigen-Antibody Complex; D001323:Autoantibodies; D001324:Autoantigens; D000939:Epitopes; D007070:Immunoglobulin A; D007074:Immunoglobulin G; D009194:Myeloma Proteins; D011134:Polysaccharides; D009439:Neuraminidase; D000116:Acetylgalactosamine; D005690:Galactose